Avanos Medical (AVNS) Total Liabilities (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Total Liabilities data on file, last reported at $268.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities changed 0.15% year-over-year to $268.0 million; the trailing twelve-month figure through Mar 2026 stood at $268.0 million (changed 0.15% YoY), and the FY2025 full-year result was $295.5 million, down 9.27% from the prior year.
• Total Liabilities slipped to $268.0 million in Q1 2026, from $295.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $511.7 million in Q3 2022 to a low of $262.7 million in Q2 2025.
• A 5-year average of $403.0 million and a median of $433.4 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 52.29% in 2022 and plunged 39.72% in 2025, its largest moves.
• Tracing AVNS's Total Liabilities over 5 years: stood at $495.7 million in 2022, then slipped by 7.99% to $456.1 million in 2023, then declined by 28.59% to $325.7 million in 2024, then fell by 9.27% to $295.5 million in 2025, then retreated by 9.31% to $268.0 million in 2026.
• Business Quant data shows AVNS's Total Liabilities at $268.0 million in Q1 2026, $295.5 million in Q4 2025, and $289.7 million in Q3 2025.